Literature DB >> 10665916

Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.

Y Allory1, F Charlotte, Y Benhamou, P Opolon, Y Le Charpentier, T Poynard.   

Abstract

Hepatitis C virus (HCV) is frequently encountered in human immunodeficiency virus (HIV)-infected patients because of common routes of transmission. Previous studies suggested that HIV infection impaired the natural course of chronic hepatitis C, with a more rapid progression to cirrhosis. However, these studies did not assess the HIV infection impact on chronic hepatitis C by taking into account the risk factors for liver fibrosis progression: alcohol, sex, age at the contamination, and duration of HCV infection. We studied liver biopsy specimens of 2 groups of 58 patients that were infected by both HCV and HIV or by HCV alone. The 2 groups were matched according those risk factors, and liver biopsy responses were evaluated with the METAVIR items. The METAVIR activity was higher in HIV-positive than HIV-negative patients. Cirrhosis was more frequent: (1) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-negative patients (10%) (P = .003), (2) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-positive patients with CD4 > 200 cells/microL (17%) (P = .04). These differences, which were linked to HIV status, might be related to the enhanced HCV replication during HIV infection or other immune mechanisms that need further studies.

Entities:  

Mesh:

Year:  2000        PMID: 10665916     DOI: 10.1016/s0046-8177(00)80201-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

Review 1.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  HIV-HCV Coinfection.

Authors:  Amrita Sethi; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

3.  Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus.

Authors:  J M Matthews-Greer; G C Caldito; S D Adley; R Willis; A C Mire; R M Jamison; K L McRae; J W King; W L Chang
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Issues in HIV/Hepatitis C Co-infection.

Authors:  Jonathan P. Moorman
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 5.  Hepatitis C and HIV co-infection: a review.

Authors:  Irena Maier; George Y Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

Review 7.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus.

Authors:  C Castaneda-Sceppa; O I Bermudez; C Wanke; J E Forrester
Journal:  J Viral Hepat       Date:  2008-12       Impact factor: 3.728

9.  Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.

Authors:  Richard K Sterling; Melissa J Contos; Paula G Smith; R Todd Stravitz; Velimir A Luketic; Michael Fuchs; Mitchell L Shiffman; Arun J Sanyal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

10.  Chronic hepatitis C.

Authors:  Jae Young Jang; Raymond T Chung
Journal:  Gut Liver       Date:  2011-06-24       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.